Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (1): 30-34.doi: 10.3736/jcim20100106

• Original Clinical Research • Previous Articles     Next Articles

Relationship between quality of life and basic syndromes of traditional Chinese medicine in patients with posthepatitic cirrhosis

 Qin Zhanga, Lei Wanga, Ping Liub   

  1. a Department of Liver Diseases, Shanghai Public Clinical Health Center, Fudan University, Shanghai 201508, China
    b Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2009-07-27 Accepted:2009-10-15 Online:2010-01-20 Published:2010-01-15
  • Contact: Ping Liu E-mail:liuping@shutcm.com

Objective

To investigate the main factors influencing the quality of life and the relationship between quality of life and basic syndromes of traditional Chinese medicine (TCM) in patients with posthepatitic cirrhosis.
Methods

The outcomes of revised Short Form-36 Health Survey (SF-36) Questionnaire in 108 patients with posthepatitic cirrhosis and the normal control population were assessed, and the related clinical information including gender, age, body mass index (BMI), course of disease, basic syndromes of disease and main laboratory parameters were collected. The data were analyzed by t-test, analysis of variance (ANOVA) and stepwise regression analysis.
Results

The Cronbach’s α coefficient of the revised SF-36 questionnaire was 0.773, indicating good consistency within the items. The outcomes of revised SF-36 and the scores of physical function, role physical, bodily pain, mental health, and social function in the patients with posthepatitic cirrhosis were significantly lower than those in the normal control population (P<0.01). Correlation analysis showed that there was a correlation between basic TCM syndromes and scores of physical function, mental health, role emotion, vitality, and general health. Stepwise regression analysis indicated that basic TCM syndromes, aspartate aminotransferase, total billirubin, albumin, and prothrombin time played major role in the quality of life in the patients with posthepatitic cirrhosis, and the values of regression coefficient were 0.262, –0.297 8, –0.483 9, –0.483 9, –0.512 3, –0.571 9 respectively.
Conclusion

The quality of life in the patients with posthepatitic cirrhosis is significantly decreased. The revised SF-36 with basic TCM syndrome items is more objective and has certain clinical practical value on measurement of quality of life in patients with posthepatitic cirrhosis.

Key words: Hepatitis, Liver cirrhosis, Quality of life, Syndrome, Traditional Chinese medicine

Table 1

Values of quality of life in normal control population and patients with posthepatitic cirrhosis ($\bar{x}$±s)"

Evaluation item Normal control (n=100) Posthepatitic cirrhosis (n=108)
Physical function 83.32±9.61 71.53±10.24**
Role physical 90.62±8.91 62.72±20.34**
Bodily pain 70.30±11.23 69.72±9.09**
General health 71.25±10.63 55.18±9.35**
Vitality 50.12±30.29 49.04±9.25
Social function 80.12±11.11 51.18±9.45**
Role emotion 69.36±21.30 68.93±11.50
Mental health 76.13±16.21 50.96±7.87**
Factors of TCM syndrome 80.10±22.43 45.66±13.68**
SF-36 77.49±8.76 60.41±9.29**

Table 2

Correlation analysis of the items of SF-36 in patients with posthepatitic cirrhosis"

Evaluation items Physical
function
Role
physical
Mental
health
Role
emotion
Social
function
Vitality Bodily
pain
General
health
Factors of
TCM syndrome
Physical function 1
Role physical 0.231 4 1
Bodily pain 0.325 6 0.102 2 1
General health 0.224 3 0.438 7 0.374 5 1
Vitality 0.252 3 0.375 6 0.268 9 0.297 4 1
Social function 0.563 4 0.391 5 0.684 2 0.512 1 0.396 8 1
Role emotion 0.238 9 0.192 8 0.402 3 0.287 9 0.201 3 0.445 2 1
Mental health 0.513 9 0.321 5 0.381 3 0.331 1 0.321 4 0.506 6 0.236 5 1
Factors of TCM syndrome 0.631 1 0.453 2 0.697 8 0.603 1 0.521 4 0.711 3 0.451 3 0.692 7 1

Table 3

Main factors influencing quality of life in patients with posthepatitic cirrhosis"

Screened factor Regression coefficient Standard error F P
Factors of TCM syndrome 0.256 2 0.054 3 4.820 0.024 7
AST –0.297 8 0.235 9 3.931 0.022 3
TB –0.483 9 0.127 6 2.865 0.031 1
Alb –0.512 3 0.049 7 2.636 0.036 0
PT –0.5719 0.215 3 2.043 0.045 1
[1] Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J . Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B[J]. J Chin Integr Med, 2003,1(2):89-98, 102
doi: 10.3969/j.issn.1008-861X.2002.01.013
刘平, 胡义扬, 刘成, 徐列明, 刘成海, 孙克伟, 胡德昌, 尹有宽, 周霞秋, 万谟彬, 蔡雄, 张志清, 叶军, 唐宝璋, 贺佳 . 扶正化瘀胶囊干预慢性乙型肝炎肝纤维化作用的多中心临床研究[J]. 中西医结合学报, 2003,1(2):89-98, 102
doi: 10.3969/j.issn.1008-861X.2002.01.013
[2] Zhang Q, Liu P, Zhang HW, Wang L, Du GL, Chen HF, Chen L, Wang JR, Wang XB . Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2006,26(8):694-697
doi: 10.7661/CJIM.2006.8.694
张琴, 刘平, 章浩伟, 王磊, 都广礼, 陈慧芬, 陈良, 王江容, 王宪波 . 900例肝炎后肝硬化中医证候判别模式的研究[J]. 中国中西医结合杂志, 2006,26(8):694-697
doi: 10.7661/CJIM.2006.8.694
[3] Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. Prevention and treatment program for viral hepatitis[J]. Zhonghua Gan Zang Bing Za Zhi, 2000,8(6):324-329
中华医学会传染病与寄生虫学会、肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志, 2000,8(6):324-329
[4] Lin XL, You LM, Ma YY, Yan J . A study on living quality and related factors of hepatitis B patients with hepatocirrhosis[J]. Hu Li Yan Jiu, 2006,20(2):304-305
doi: 10.3969/j.issn.1009-6493.2006.04.009
林晓岚, 尤黎明, 马盈盈, 颜君 . 乙型病毒性肝炎后肝硬化病人生存质量及相关因素的研究[J]. 护理研究, 2006,20(2):304-305
doi: 10.3969/j.issn.1009-6493.2006.04.009
[5] Li WW, Li Q, Wang JB, Li XY, Zhang LX, An Y, Zhang QG . Factors associated with health-related quality of life in patients with liver cirrhosis[J]. Shandong Da Xue Xue Bao Yi Xue Ban, 2006,44(9):885-888
doi: 10.3969/j.issn.1671-7554.2006.09.007
李雯雯, 李强, 王晶波, 李晓迎, 张立新, 安勇, 张琴冈 . 乙肝肝硬化患者生活质量相关因素分析[J]. 山东大学学报(医学版), 2006,44(9):885-888
doi: 10.3969/j.issn.1671-7554.2006.09.007
[6] Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD . Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan[J]. World J Gastroenteol, 2005,11(47):7494-7498
doi: 10.3748/wjg.v11.i47.7494
[7] Park CK, Park SY, Kim ES, Park JH, Hyun DW, Yun YM, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YH, Park SG . Assessment of quality of life and associated factor in patients with chronic viral liver disease[J]. Taehan Kan Hakhoe Chi, 2003,9(3):212
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[3] Zeinab Vafaeipour, Bibi Marjan Razavi, Hossein Hosseinzadeh. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review. Journal of Integrative Medicine, 2022, 20(3): 193-203.
[4] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[5] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[6] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[7] Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.
[8] Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.
[9] Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394.
[10] Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine, 2021, 19(5): 395-407.
[11] Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438.
[12] Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[13] Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299.
[14] Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281.
[15] Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228